Related Experiment Video
Updated: Jul 18, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Could agomelatine be the ideal antidepressant?
S R Pandi-Perumal1, Venkatramanujan Srinivasan, D P Cardinali
1Comprehensive Center for Sleep Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Mount Sinai School of Medicine, 1176 5 Avenue, 6 Floor, Box 1232, New York, NY 10029, USA. pandiperumal@gmail.com
Expert Review of Neurotherapeutics
|December 6, 2006
Summary
Agomelatine, a novel antidepressant, effectively treats depression by targeting melatonin and serotonin receptors. It offers a superior response rate, particularly in severe cases, and helps regulate sleep-wake cycles.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Depressive disorders are a major global health issue, causing significant disability and mortality.
- Current antidepressants, while effective, often have undesirable side effects.
- Many patients do not achieve full remission with existing treatments.
Purpose of the Study:
- To evaluate the efficacy and tolerability of agomelatine, a novel antidepressant.
- To investigate agomelatine's unique mechanism of action involving melatonin and serotonin receptors.
- To assess agomelatine's potential for treating severe depressive disorders and regulating sleep-wake rhythms.
Main Methods:
- Agomelatine's antidepressant and anxiolytic effects were studied in animal models.
- Clinical efficacy and tolerability were assessed in large, multinational, placebo-controlled trials.
- Response rates in severely depressed patients were specifically analyzed.
Main Results:
- Agomelatine demonstrated effectiveness in animal models of depression and anxiety.
- Clinical trials confirmed agomelatine as an effective and well-tolerated antidepressant in acute treatment.
- Agomelatine showed a superior response rate in severely depressed patients compared to standard treatments.
Conclusions:
- Agomelatine's novel mechanism of action, as a melatonin and serotonin receptor modulator, provides antidepressant effects.
- Its ability to regulate sleep-wake rhythms contributes to its clinical advantage.
- Agomelatine presents a promising therapeutic option for depressive disorders, especially in patients with severe symptoms.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...